Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...

Gilead Sciences, Inc. (NASDAQ: GILD) and Kymera Therapeutics, Inc. (NASDAQ: KYMR), today announced that they have entered ...

Move your body. If you’ll be sitting in a plane or a car for hours, be sure to get up and move as often as possible. “Travel, ...

AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat ...

A teacher had to have her tongue rebuilt from her arm after what she thought was a mouth ulcer - turned out to be terminal cancer. Emma Byron, 45, was first diagnosed with Stage 1 oral squamous ...

June is National Cancer Survivors Month and health officials say healing is not only about healing your body but also your ...

A pioneering study at King's College London, University of Oxford and Guy's and St Thomas' NHS Foundation Trust has ...

David Muir shares 3D scans of Titanic that reveal new insight into its final moments ...

Dr. Prantesh Jain and Dr. Joshua Sabari delved into the numerous advances in NSCLC following 2025 ASCO, highlighting the ...

Dr. Joshua K. Sabari and Dr. Julia E. McGuinness discussed the SERENA-6 trial and its outcomes for patients with ESR1-mutated HR+/HER2— breast cancer.

As immunotherapy becomes a cornerstone of cancer treatment, some of the top U.S. cancer centers and health systems are accelerating research efforts to identify the biological mechanisms behind ...

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary ...